Annual EBITDA
$3.22B$21.00M+0.66%
Summary
- Current Value
- As of today, MDLN annual EBITDA is $3.22B, up +0.66% on
- Historical Performance
- MDLN annual EBITDA is up +78.76% over the past 3 years, up +78.76% over the past 5 years
- All-Time High Comparison
- MDLN annual EBITDA is currently at its all-time high
- 3-Year Low Comparison
- MDLN annual EBITDA is +78.76% above its 3-year low of $1.80B reached on an earlier date
- Sector Comparison
- MDLN annual EBITDA is higher than 96.64% of companies in Healthcare sector
EBITDA Chart
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EBITDA | $3.22B | +0.7% | +78.8% | +78.8% | +78.8% | |
| Quarterly EBITDA | $676.00M | -19.3% | -15.7% | -15.7% | -15.7% | |
| TTM EBITDA | $3.11B | -4.1% | +287.2% | +287.2% | +287.2% | |
| Price | $36.56 | – | – | – | – | |
| PE Ratio | 30.58 | – | – | – | – | |
| Annual Revenue | $28.43B | +11.5% | +32.6% | +32.6% | +32.6% | |
| Annual EPS | $1.43 | -4.9% | +4660.1% | +4660.1% | +4660.1% | |
| $2.21B | -0.6% | +154.3% | +154.3% | +154.3% | ||
| Annual Net Income | $1.16B | -3.6% | +4728.0% | +4728.0% | +4728.0% |
EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $3.22B | at high | |
| 5Y | $3.22B | at high | |
| All | $3.22B | at high |
EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $1.80B | N/A | +78.8% |
| 5Y | $1.80B | +78.8% | |
| All | $1.80B | +78.8% |
EBITDA History
| Year | Value | Change |
|---|---|---|
| $3.22B | +0.7% | |
| $3.20B | +33.7% |
| Year | Value | Change |
|---|---|---|
| $2.40B | +32.8% | |
| $1.80B | - |
FAQ
What is the current annual EBITDA of MDLN?
As of today, MDLN annual EBITDA is $3.22B
What is 1-year change in MDLN annual EBITDA?
MDLN annual EBITDA is up +0.66% year-over-year
What is 3-year change in MDLN annual EBITDA?
MDLN annual EBITDA is up +78.76% over the past 3 years
How far is MDLN annual EBITDA from its all-time high?
MDLN annual EBITDA is currently at its all-time high
How does MDLN annual EBITDA rank versus sector peers?
MDLN annual EBITDA is higher than 96.64% of companies in Healthcare sector
When is MDLN next annual earnings release?
As of today, the next annual earnings release for MDLN has not been scheduled
EBITDA Formula
EBITDA = Net Income + + +
Quarterly EBITDA
$676.00M$47.00M-6.50%
Summary
- Current Value
- As of today, MDLN quarterly EBITDA is $676.00M, down -6.50% on
- Historical Performance
- MDLN quarterly EBITDA is down -19.33% year-over-year, down -15.71% over the past 3 years
- All-Time High Comparison
- MDLN quarterly EBITDA is currently -23.09% below its historical high of $879.00M set on
- 3-Year Low Comparison
- MDLN quarterly EBITDA is at its 3-year low
- Sector Comparison
- MDLN quarterly EBITDA is higher than 96.03% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EBITDA | $676.00M | -6.5% | -19.3% | -15.7% | -15.7% | |
| Annual EBITDA | $3.22B | – | +0.7% | +78.8% | +78.8% | |
| TTM EBITDA | $3.11B | -5.0% | -4.1% | +287.2% | +287.2% | |
| Price | $36.56 | -23.1% | – | – | – | |
| PE Ratio | 30.58 | -6.9% | – | – | – | |
| Quarterly Revenue | $7.35B | -5.6% | +10.7% | +19.5% | +19.5% | |
| Quarterly EPS | $0.15 | -31.9% | -62.1% | -58.6% | -58.6% | |
| $422.00M | -8.7% | -28.6% | -25.3% | -25.3% | ||
| Quarterly Net Income | $239.00M | +32.8% | -25.8% | -19.0% | -19.0% |
Quarterly EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $879.00M | -23.1% | |
| 3Y | $879.00M | -23.1% | |
| 5Y | $879.00M | -23.1% | |
| All | $879.00M | -23.1% |
Quarterly EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $676.00M | at low | |
| 3Y | $676.00M | at low | |
| 5Y | $676.00M | at low | |
| All | $676.00M | at low |
Quarterly EBITDA History
| Month | Value | Change |
|---|---|---|
| $676.00M | -6.5% | |
| $723.00M | -12.6% | |
| $827.00M | -5.9% | |
| $879.00M | +4.9% | |
| $838.00M | +1.7% |
| Month | Value | Change |
|---|---|---|
| $824.00M | +0.2% | |
| $822.00M | +8.9% | |
| $755.00M | -5.9% | |
| $802.00M | - |
FAQ
What is the current quarterly EBITDA of MDLN?
As of today, MDLN quarterly EBITDA is $676.00M
What is MDLN quarterly EBITDA most recent change?
MDLN quarterly EBITDA was down -6.50% on March 31, 2026
What is 1-year change in MDLN quarterly EBITDA?
MDLN quarterly EBITDA is down -19.33% year-over-year
How far is MDLN quarterly EBITDA from its all-time high?
MDLN quarterly EBITDA is currently -23.09% below its historical high of $879.00M set on June 30, 2025
How does MDLN quarterly EBITDA rank versus sector peers?
MDLN quarterly EBITDA is higher than 96.03% of companies in Healthcare sector
When is MDLN next earnings release?
The next earnings release for MDLN is on
EBITDA Formula
EBITDA = Net Income + + +
TTM EBITDA
$3.11B$162.00M-4.96%
Summary
- Current Value
- As of today, MDLN TTM EBITDA is $3.11B, down -4.96% on
- Historical Performance
- MDLN TTM EBITDA is down -4.14% year-over-year, up +287.16% over the past 3 years
- All-Time High Comparison
- MDLN TTM EBITDA is currently -7.81% below its historical high of $3.37B set on
- 3-Year Low Comparison
- MDLN TTM EBITDA is +287.16% above its 3-year low of $802.00M reached on
- Sector Comparison
- MDLN TTM EBITDA is higher than 96.21% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EBITDA | $3.11B | -5.0% | -4.1% | +287.2% | +287.2% | |
| Annual EBITDA | $3.22B | – | +0.7% | +78.8% | +78.8% | |
| Quarterly EBITDA | $676.00M | -6.5% | -19.3% | -15.7% | -15.7% | |
| Price | $36.56 | -23.1% | – | – | – | |
| PE Ratio | 30.58 | -6.9% | – | – | – | |
| TTM Revenue | $29.14B | +2.5% | +12.1% | +373.8% | +373.8% | |
| TTM EPS | $1.20 | -17.3% | -22.1% | +224.2% | +224.2% | |
| $2.09B | -7.5% | -7.3% | +269.4% | +269.4% | ||
| TTM Net Income | $1.07B | -7.2% | -12.5% | +264.1% | +264.1% |
TTM EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $3.37B | -7.8% | |
| 3Y | $3.37B | -7.8% | |
| 5Y | $3.37B | -7.8% | |
| All | $3.37B | -7.8% |
TTM EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $3.11B | at low | |
| 3Y | $802.00M | +287.2% | |
| 5Y | $802.00M | +287.2% | |
| All | $802.00M | +287.2% |
TTM EBITDA History
| Month | Value | Change |
|---|---|---|
| $3.11B | -5.0% | |
| $3.27B | -3.0% | |
| $3.37B | +0.1% | |
| $3.36B | +3.8% | |
| $3.24B | +1.1% |
| Month | Value | Change |
|---|---|---|
| $3.20B | +34.6% | |
| $2.38B | +52.8% | |
| $1.56B | +94.1% | |
| $802.00M | - |
FAQ
What is the current TTM EBITDA of MDLN?
As of today, MDLN TTM EBITDA is $3.11B
What is MDLN TTM EBITDA most recent change?
MDLN TTM EBITDA was down -4.96% on March 31, 2026
What is 1-year change in MDLN TTM EBITDA?
MDLN TTM EBITDA is down -4.14% year-over-year
How far is MDLN TTM EBITDA from its all-time high?
MDLN TTM EBITDA is currently -7.81% below its historical high of $3.37B set on September 30, 2025
How does MDLN TTM EBITDA rank versus sector peers?
MDLN TTM EBITDA is higher than 96.21% of companies in Healthcare sector
When is MDLN next earnings release?
The next earnings release for MDLN is on
EBITDA Formula
EBITDA = Net Income + + +
Data Sources & References
- MDLN Official Website www.medline.com
- MDLN Profile on Yahoo Finance finance.yahoo.com/quote/MDLN
- MDLN Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/mdln